Category 'CiteAb news'

  1. Have you seen our widget in action on distributor sites?

    Exciting news – this week our citation widget has been put into use for the first time on a distributor website. Previously a number of suppliers have used our citation widget on their websites, including Cell Signaling Technologies, US Biological, Rockland Immunochemicals and Bethyl Laboratories. We also provided our first ELISA citation widget to Active […]

  2. Thank you to our 50k monthly users!

    Great news – you’re here using CiteAb and you’re in really good company. A lot of it! The CiteAb user base has grown and grown, and we are now helping over 50,000 users like you to find quality antibodies every month. In addition, we have now got over a million citations listed in the CiteAb […]

  3. Catch up on your free data!

    Over recent weeks we’ve covered loads of different data stories here on our blog and have given away free data with each of them. We thought it might be helpful to provide a quick recap, and links to help you collect any of the free data sets you might have missed out on. We reported […]

  4. New text mining tech gives autophagy insights

    We recently told you that we have some tech updates in the pipeline – and today we are going to speak to one of our developers, Matt Helsby, to show you a new piece of tech we’ve created. So Matt, what’s new? “Hi there! Today we’re launching an update to our text mining technology which […]

  5. Fake antibodies cause stir in Chinese market

    Last week we reported on the continued fast paced growth of the Chinese antibody market, and mentioned that this has not been without its perils. Today we’re going to take a look at the lucrative market for fake research reagents that has arisen in China and was recently exposed by science journal Nature. Nature reports […]

  6. New team members at CiteAb

    We’re excited to be welcoming three new people to the CiteAb team – two product managers and a developer. Alicia Cooper and Rebecca Sadler join us as product managers as CiteAb continues to grow and offer ever more complex data sets and market reports. Rebecca graduates from her biology degree at the University of Bath […]

  7. We’re working with the GBSI to improve ICC antibody validation

    Our founder, Dr Andrew Chalmers, is leading an Antibody Validation Working Group for the Global Biological Standards Institute (GBSI) focused on improving the validation of antibodies used for ICC. The group is one of nine created by the GBSI with the aim of creating a series of antibody validation guidelines for each of the most […]

  8. CiteAb: now more than just antibodies!

    Here at CiteAb we have recently developed our technology so that we can now collate data on multiple reagent types – not just antibodies. This means we can now give a picture of the global market for different types of reagent, in the same way that we have for antibodies. Our founder, Dr Andrew Chalmers, […]

  9. We’re recruiting! Graduate developer wanted to join our team.

        THE DEADLINE FOR APPLICATIONS HAS NOW CLOSED     Here at CiteAb we’re looking for a graduate in Computer Science to join our team and help to develop our industry leading data curation, machine learning and search engine technology. Job title: Graduate Developer Location: Bath Salary: Starting £22 – £27k Hours: Full Time. Part […]

  10. We’re recruiting! Biologist or Chemist wanted to join our team.

        THE DEADLINE FOR APPLICATIONS HAS NOW CLOSED     Here at CiteAb we’re looking for a graduate in biological sciences or chemistry to join our team and manage some of our key data products. Job title: Data product manager (Biological Sciences or Chemistry) Location: Bath Salary: Competitive (Based on qualifications and experience) Hours: Full […]